Objective: To describe the clinical results and the degree of satisfaction of patients submitted to thoracic sympathectomy at the level of the fourth and fifth ribs (R4-R5) for the treatment of axillary hyperhidrosis.

Methods: We included 118 patients diagnosed with axillary hyperhidrosis and having undergone axillary sympathectomy at the R4-R5 level between March of 2003 and December of 2007 at the Paraná Federal University Hospital de Clínicas, located in the city of Curitiba, Brazil. All procedures were carried out by the same surgeon. Data regarding the resolution of axillary hyperhidrosis and the degree of patient satisfaction with the surgical outcome, as well as compensatory hyperhidrosis in the early and late postoperative periods (after 7 days and after 12 months, respectively), were collected.

Results: Of the 118 patients evaluated, 99 (83.9%) and 81 (68.6%) showed complete resolution of the symptoms in the early and late postoperative periods, respectively. Compensatory hyperhidrosis occurred in 49 patients (41.5%) in the early postoperative period and in 77 (65.2%) in the late postoperative period. Of those 77, 55 (71.4%) categorized the compensatory hyperhidrosis as mild. In the early postoperative period, 110 patients (93.2%) were satisfied with the surgical results, and 104 (88.1%) remained so in the late postoperative period.

Conclusions: Sympathectomy at the R4-R5 level is efficient in the resolution of primary axillary hyperhidrosis. The degree of patient satisfaction with the long-term surgical results is high. Mild compensatory hyperhidrosis is the main side effect associated with this technique.

Download full-text PDF

Source
http://dx.doi.org/10.1590/s1806-37132011000100003DOI Listing

Publication Analysis

Top Keywords

axillary hyperhidrosis
16
compensatory hyperhidrosis
16
late postoperative
16
postoperative period
12
thoracic sympathectomy
8
sympathectomy level
8
level fourth
8
fourth ribs
8
treatment axillary
8
hyperhidrosis
8

Similar Publications

Evaluation of Efficacy and Safety of miraDry Procedure in the Treatment of Primary Axillary Hyperhidrosis.

Aesthetic Plast Surg

January 2025

Department of Plastic, Reconstructive and Aesthetic Surgery, Academic Hospital Feldkirch, Carinagasse 47, 6807, Feldkirch, Austria.

Introduction: Primary axillary hyperhidrosis significantly impacts the quality of life of affected individuals. miraDry, a non-invasive local precisely controlled thermal energy procedure, represents a promising treatment option. This retrospective analysis aimed to evaluate the treatment success and patient safety following miraDry procedure in the treatment of primary axillary hyperhidrosis.

View Article and Find Full Text PDF

Background: Primary axillary hyperhidrosis has limited noninvasive and effective treatment, and we present the use of sofpironium bromide as a promising treatment option. We aimed to assess the efficacy and safety of sofpironium in patients with primary hyperhidrosis.

Methods: We systematically searched the databases for Studies that assessed sofpironium bromide in patients with primary axillary hyperhidrosis.

View Article and Find Full Text PDF

A Commentary on an Article Entitled: "Enhancing Anatomical Understanding of the Dermal Microvascular Plexus for Improved Flap Outcomes in Axillary Hyperhidrosis".

Ann Plast Surg

January 2025

Division of Plastic and Reconstruction, Department of Surgery, Chia-Yi Christian Hospital, Taiwan Department of Chemistry and Biochemistry, National Chung Cheng University, Taiwan.

View Article and Find Full Text PDF

Experience of negative pressure fractional microneedle radiofrequency therapy for axillary osmidrosis: a case study.

Arch Dermatol Res

December 2024

Department of Plastic Surgery, ZhongshanCity People's Hospital, 2 Sunwen East Road, Zhongshan, 528400, Guangdong, China.

Background: Negative pressure fractional microneedle radiofrequency (NPFMR) therapy has emerged as a potential minimally invasive treatment for axillary osmidrosis (AO), a condition characterized by persistent strong body odor from the armpit area.

Methods: This case study aims to assess the efficacy and safety of NPFMR for AO treatment. From January to September 2024, 30 patients with AO were recruited, with a gender distribution of 19 females and 11 males, aged 17-34 years (mean 23).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!